Document:

*Exhibit 10.17

Exhibit 10.17

THE SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) OR UNDER ANY APPLICABLE STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A CURRENT AND EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS WITH RESPECT TO SUCH SECURITIES, OR AN OPINION SATISFACTORY TO THE ISSUER AND ITS COUNSEL TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS.
 
	
			
	WARRANT NO. 201211-050
	  
	Date: November     , 2012

WARRANT TO PURCHASE COMMON STOCK

AutoGenomics, Inc., a Delaware corporation (the “Company”), hereby certifies that A R Properties (the “Holder”), is entitled to purchase, on the terms and conditions contained herein, 26,980 fully paid, validly issued and nonassessable shares (the “Warrant Shares”) of common stock, no par value, of the Company (the “Common Stock”), at an initial exercise price of $1.50 per Warrant Share (the “Exercise Price”). This Warrant has been approved by the Board of Directors of the Company and is issued pursuant to the terms of that certain Subscription Agreement, dated as of the date hereof, by and between the Company and the Holder (the “Subscription Agreement”). The number of Warrant Shares and the Exercise Price are subject to adjustment as provided in Section 2 below.

This Warrant is subject to the following terms and conditions:

1. Exercisability and Exercise.

1.1 Method of Exercise. This Warrant may be exercised in whole at the option of the Holder at any time and from time to time from the date hereof through and including November     , 2017 (the “Exercise Period”), by delivering to the Company payment of the aggregate Exercise Price for the Warrant Shares being purchased by check or wire transfer, together with an executed Notice of Exercise in the form attached as Exhibit I hereto.

1.2 Effectiveness of Exercise; Procedure. The exercise of this Warrant shall be deemed to have been effected immediately prior to the close of business on the day on which the Holder delivers the Notice of Exercise to the Company together with payment of the Exercise Price and satisfies all of the requirements of this Section 1. Upon such exercise, the Holder will be deemed a shareholder of record of the Warrant Shares with all rights of a shareholder (including, without limitation, all voting rights with respect to such Warrant Shares and all rights to receive any dividends with respect to such Warrant Shares). In the event of any exercise of the rights represented by this Warrant, certificates for the shares of Common Stock so purchased shall be delivered to the Holder within a reasonable time by the transfer agent of the Company by crediting the account of the Holder’s broker with The Depositary Trust Company through its Deposit Withdrawal Agent Commission system if the Company is a participant in such system, and otherwise by physical delivery to the address specified in the Notice of Exercise. The Company shall not be required to issue fractional shares upon the exercise of this Warrant. In lieu of any fractional share to which the Holder would otherwise be entitled, the Holder shall be entitled, at its option, to receive either (a) a cash payment equal to the excess of the fair market value, as determined by the Board of Directors of the Company in good faith, for such fractional share above the Exercise Price for such fractional share (as mutually determined by the Company and the Holder) or (b) a whole share if the Holder tenders the Exercise Price for one whole share.
 
2. Adjustments.

2.1 Reorganizations, Mergers, Recapitalizations and Reclassifications.

(a) Change of Control. If at any time a Change of Control (as defined below) occurs and, pursuant to the terms of such Change of Control, shares of common stock of the successor or acquiring corporation, or any cash, shares of stock or other securities or property of any nature whatsoever (including warrants or other subscription or purchase rights) in addition to or in lieu of common stock of the successor or acquiring corporation (“Other Property”), are to be received by or distributed to the holders of Common Stock of the Company, then the Holder shall have the right thereafter to receive upon exercise of this Warrant (and this Warrant shall thereafter be exercisable only for) the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and Other Property receivable upon or as a result of such Change of Control by a holder of the number of shares of Common Stock for which this Warrant is 

Page 1

exercisable immediately prior to such Change of Control. In case of any such Change of Control, the successor or acquiring corporation (if other than the Company) shall expressly assume the due and punctual observance and performance of each and every covenant and condition of this Warrant to be performed and observed by the Company and all the obligations and liabilities hereunder, subject to such modifications as may be deemed appropriate (as determined in good faith by resolution of the Board of Directors of the Company) in order to provide for adjustments of the Warrant Shares for which this Warrant is exercisable which shall be as nearly equivalent as practicable to the adjustments provided for in this Section 2.1(a). For purposes of this Section 2.1(a), “common stock of the successor or acquiring corporation” shall include stock of such corporation of any class which is not preferred as to dividends or assets over any other class of stock of such corporation and which is not subject to redemption. The foregoing provisions of this Section 2.1(a) shall similarly apply to any successive Change of Control. As used in this Warrant, a “Change of Control” shall mean (i) a transaction or series of transactions (other than an offering of common stock of the Company to the general public through a registration statement filed with the Securities and Exchange Commission) whereby any “person” or related “group” of “persons” (as such terms are used in Sections 13(d) and 14(d)(2) of the Securities Exchange Act of 1934, as amended from time to time (the “Exchange Act”)) (other than the Company, any of its subsidiaries, an employee benefit plan maintained by the Company or any of its subsidiaries or a “person” that, prior to such transaction, directly or indirectly controls, is controlled by, or is under common control with, the Company) directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act) of securities of the Company possessing more than 50% of the total combined voting power of the Company’s securities outstanding immediately after such acquisition; or (ii) the consummation by the Company (whether directly involving the Company or indirectly involving the Company through one or more intermediaries) of (A) a merger, consolidation, reorganization or business combination, (B) a sale or other disposition of all or substantially all of the Company’s assets in any single transaction or series of related transactions or (C) the acquisition of assets or stock of another entity, in each case other than a transaction (1) which results in the Company’s voting securities outstanding immediately before the transaction continuing to represent (either by remaining outstanding or by being converted into voting securities of the Successor Entity (as defined below)) directly or indirectly, at least a majority of the combined voting power of the Successor Entity’s outstanding voting securities immediately after the transaction, and (2) after which no person or group beneficially owns voting securities representing 50% or more of the combined voting power of the Successor Entity; provided, however, that no person or group shall be treated for purposes of this Section 2.1(a)(ii)(C)(2) as beneficially owning 50% or more of combined voting power of the Successor Entity solely as a result of the voting power held in the Company prior to the consummation of the transaction. As used in this Section 2.1(a)(ii)(C), the “Successor Entity” shall mean, as applicable, the Company or the person that, as a result of the Change of Control, controls, directly or indirectly, the Company or owns, directly or indirectly, all or substantially all of the Company’s assets or otherwise succeeds to the business of the Company.

(b) Other Events. If, at any time after the date of this Warrant, (i) the outstanding shares of Common Stock issuable upon exercise of this Warrant are changed into, or exchanged for, a different number or kind of shares or securities of the Company through a reorganization, merger, recapitalization or reclassification which does not constitute a Change of Control, or (ii) the number of outstanding shares of such Common Stock is changed through a stock split, reverse stock split, stock dividend, stock consolidation or similar capital adjustment, an appropriate adjustment shall be made by the Board, if necessary, in the Exercise Price and in the number or kind of shares into which this Warrant is exercisable. In making such adjustments, or in determining that no such adjustments are necessary, the Board may rely upon the advice of counsel and accountants to the Company.

2.2 Notice of Adjustment. Upon the occurrence of each adjustment or readjustment of the Exercise Price or the number and kind of securities into which this Warrant is exercisable, the Company at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to the Holder a certificate setting forth such adjustment or readjustment (including the kind and amount of securities, cash or other property for which this Warrant shall be exercisable and the Exercise Price) and showing in detail the facts upon which such adjustment or readjustment is based. The Company shall, upon the written request at any time of the Holder, furnish or cause to be furnished to the Holder a certificate setting forth (i) the Exercise Price then in effect and (ii) the number and kind of shares of capital stock and the amount, if any, of other securities, cash or property which then would be received upon the exercise of this Warrant.

3. Reservation of Stock. The Company shall at all times have authorized, and reserved for the purpose of the issue upon exercise of this Warrant, a sufficient number of shares of its Common Stock to provide for the exercise of this Warrant.

4. Notices of Record Date, etc. In the event the Company shall take a record of the holders of any of its Common Stock for the purpose (a) of entitling or enabling them to receive any dividend or other distribution, or to receive any right to subscribe for or purchase any shares of stock of any class or any other securities, or to receive any other right; (b) of any capital reorganization of the Company, any reclassification of the stock of the Company or any Change of Control; or (c) of the voluntary or involuntary dissolution, liquidation or winding-up of the Company; then, and in each such case, the Company will mail or cause to be mailed to the Holder a notice specifying, as the case may be, (x) the record date for such dividend, 

distribution or right, and the amount and character of such dividend, distribution or right, or (y) the effective date on which such reorganization, reclassification, consolidation, Change of Control, dissolution, liquidation or winding-up is to take place, and the time, if any is to be fixed, as of which the holders of record of Common Stock of the Company shall be entitled to exchange their shares for securities or other property deliverable upon such reorganization, reclassification, consolidation, Change of Control, dissolution, liquidation or winding-up. Such notice shall be mailed at least ten days prior to the record date or effective date for the event specified in such notice.

5. Exchange of Warrant. Upon the surrender by the Holder, properly endorsed, to the Company at the principal office of the Company, the Company will issue and deliver to or upon the order of such Holder, at the Company’s expense, a new Warrant or Warrants of like tenor, in the name of the Holder or as the Holder may direct, without charge for any issuance or transfer tax or other cost incurred by the Company, calling in the aggregate on the face or faces thereof for the number of shares of capital stock (or other securities, cash and/or property) then issuable upon exercise of this Warrant. The Company will at no time close its transfer books against the transfer of the Warrant Shares issued or issuable upon the exercise of this Warrant in any manner which interferes with the timely exercise of this Warrant.

6. Replacement of Warrant. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and (in the case of loss, theft or destruction) upon delivery of an indemnity agreement (with surety if reasonably required) in an amount reasonably satisfactory to the Company, or (in the case of mutilation) upon surrender and cancellation of this Warrant, the Company will issue, in lieu thereof, a new Warrant of like tenor. Any such new Warrant executed and delivered shall constitute an additional contractual obligation on the part of the Company, whether or not the Warrant so lost, stolen, destroyed or mutilated shall be at any time enforceable by anyone.

7. Transfer of Warrant. This Warrant and all rights hereunder are transferable, in whole, upon surrender of this Warrant with a properly executed assignment (in the form of Exhibit II hereto) at the principal office of the Company. However, as a condition to such transfer, either (a) this Warrant must be registered under the Securities Act of 1933, as amended (the “Act”), and all applicable state securities laws with respect thereto or (b) the Company must first be furnished with an opinion of legal counsel, reasonably satisfactory to the Company, to the effect that such transfer is exempt from the registration requirements of the Act.

8. Miscellaneous.

8.1 Expiration. This Warrant shall expire at the close of business on the date that is five (5) years from the date hereof.

8.2 Restrictive Legend. This Warrant, any Warrant issued upon transfer of this Warrant and the shares of Common Stock issued upon exercise of this Warrant shall be imprinted with substantially the following legend, in addition to any legends required under applicable state securities laws:

“THE SECURITIES REPRESENTED BY THIS WARRANT/CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) OR UNDER ANY APPLICABLE STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A CURRENT AND EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS WITH RESPECT TO SUCH SECURITIES, OR AN OPINION SATISFACTORY TO THE ISSUER AND ITS COUNSEL TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS.”

8.3 No Voting Rights. Nothing contained in this Warrant shall be construed as conferring upon Holder by virtue of holding this Warrant (i) the right to vote or to consent as a shareholder in respect of meetings of shareholders for the election of directors of the Company or any other matter, (ii) the right to receive dividends or (iii) any other rights as a shareholder of the Company.

8.4 Compliance with Securities Laws. Holder agrees to exercise and transfer (to the extent permitted pursuant to Section 7 hereof) this Warrant in compliance with all applicable federal and state securities laws and agrees to cooperate with the Company in taking any and all action which may be deemed necessary or desirable to ensure such compliance, including, without limitation, the execution and delivery of one or more documents as requested by the Company representing as to certain matters and acknowledging the restricted nature of the Common Stock to be issued.

8.5 Modification And Waiver. This Warrant and any provision hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the party against which enforcement is sought.

8.6 Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall be a Saturday or a Sunday or shall be a legal holiday, then such action may be taken or such right may be exercised on the next succeeding day not a Saturday or a Sunday or a legal holiday.

8.7 Successors and Assigns. This Warrant shall be binding upon any successors or assigns of the Company.

8.8 Notices. All notices, requests, consents and demands with respect to this Warrant shall be made in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed telex or facsimile if sent during normal business hours of the recipient, if not, then on the next business day, (c) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the Company at 2980 Scott Street, Vista, California, and to Holder at the applicable address set forth on the applicable signature page to the Subscription Agreement or at such other address as the Company or Holder may designate by ten (10) days advance written notice to the other parties hereto.

8.9 Governing Law. This Warrant shall be construed and enforced in accordance with, and the rights of the parties shall be governed by, the laws of the jurisdiction of incorporation of the Company, without regard to its principles of choice of law.

[Signature Page to Warrant to Purchase Common Stock]

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed and issued by its duly authorized representative on the date first above written.
 
	
		
	AUTOGENOMICS, INC.

	 
	 

	By:
	 

	 
	Fareed Kureshy

	 
	Its President and CEO

Page 5

Schedule to Exhibit 10.17
The following common stock warrants are substantially identical in all material respects to the representative warrant to which this schedule is attached and which is filed as an exhibit to AutoGenomics, Inc.’s registration statement on Form S-1 (the “Registration Statement”), except as to the parties thereto, number of warrant shares and exercise prices set forth below. The number of warrant shares and exercise prices presented in Exhibit 10.17 and in the chart below are presented as set forth in their respective warrants and, except for the warrant marked with an asterisk below, do not reflect the effect of our January 2013 1-for-0.33 reverse common stock split.  The number of warrant shares after our January 2013 reverse stock split is equal to the product of the number of warrant shares presented and 0.33, rounded up to the nearest whole number.  Warrants with an exercise price of $1.50, $1.75, $3.00, $4.00 and $5.00 per share, as presented in the chart below, are exercisable, after giving effect to our January 2013 reverse stock split, at a price of $4.55, $5.30, $9.09, $12.12 and $15.15 per share, respectively.
These other common stock warrants are not being filed with the Registration Statement, pursuant to Instruction 2 to Item 601 of Regulation S-K promulgated under the Securities Exchange Act of 1934, as amended.	
								
	Number
	Holder
	Warrant
Shares
	 
	Exercise
Price

	201211-051
	A R Properties
	71,000
	

	 
	$
	1.50
	

	201211-078
	Shugart Investments
	71,000
	

	 
	$
	1.50
	

	201211-052
	A R Properties
	28,400
	

	 
	$
	1.50
	

	201211-076
	R&M Investments
	14,200
	

	 
	$
	1.50
	

	201211-067
	Kannappan Family Trust
	7,100
	

	 
	$
	1.50
	

	201211-053
	A R Properties
	37,500
	

	 
	$
	1.50
	

	201211-063
	IAS Management, LLC
	37,500
	

	 
	$
	1.50
	

	201211-070
	Levin Family Revocable Trust
	42,600
	

	 
	$
	1.50
	

	201211-081
	The Testman Trust
	14,200
	

	 
	$
	1.50
	

	201211-080
	Terrence A Noonan
	7,100
	

	 
	$
	1.50
	

	201211-054
	A R Properties
	284,000
	

	 
	$
	1.50
	

	201211-071
	Levin Family Revocable Trust
	28,400
	

	 
	$
	1.50
	

	201211-064
	IAS Management, LLC
	71,000
	

	 
	$
	1.50
	

	201211-059
	Cyndy Reinking
	71,000
	

	 
	$
	1.50
	

	201211-066
	Joseph Sullivan
	2,840
	

	 
	$
	1.50
	

	201211-072
	McGrath Family Trust
	42,600
	

	 
	$
	1.50
	

	201211-082
	The Testman Trust
	15,620
	

	 
	$
	1.50
	

	201211-083
	The Testman Trust
	30,000
	

	 
	$
	1.50
	

	201211-088
	William Davidson
	30,000
	

	 
	$
	1.50
	

	201211-055
	A R Properties
	30,000
	

	 
	$
	1.50
	

	201211-065
	James Mamakos
	30,000
	

	 
	$
	1.50
	

	201211-086
	Thomas Reise
	15,000
	

	 
	$
	1.50
	

	201211-077
	Roger MacFarlane
	60,000
	

	 
	$
	1.50
	

	201211-056
	A R Properties
	60,000
	

	 
	$
	1.50
	

	201211-057
	A R Properties
	62,500
	

	 
	$
	1.50
	

	201211-087
	Thomas V Hennessey, Jr
	10,000
	

	 
	$
	1.50
	

	201211-061
	George F Ohrstrom
	62,500
	

	 
	$
	1.50
	

	201211-085
	Thomas Campbell Jackson
	62,500
	

	 
	$
	1.50
	

	201211-058
	A R Properties
	75,000
	

	 
	$
	1.50
	

	201211-069
	Kentor Trust U/A dated 09/18/2002
	24,080
	

	 
	$
	1.50
	

	201211-062
	God’s Gift
	71,000
	

	 
	$
	1.50
	

	201211-079
	Strader Family Trust
	7,100
	

	 
	$
	1.50
	

	201211-068
	Kentor Trust U/A dated 09/18/2002
	6,745
	

	 
	$
	1.50
	

	201211-073
	National Healthcare Services
	85,200
	

	 
	$
	1.50
	

	201211-074
	National Healthcare Services
	85,200
	

	 
	$
	1.50
	

	201211-075
	National Healthcare Services
	170,400
	

	 
	$
	1.50
	

Page 6

	
								
	Number
	Holder
	Warrant
Shares
	 
	Exercise
Price

	201211-084
	The Testman Trust
	7,500
	

	 
	$
	1.50
	

	201211-060
	Donald E Pogorzelski Trust
	75,000
	

	 
	$
	1.50
	

	201211-028
	Kentor Trust U/A dated 09/18/2002
	39,922
	

	 
	$
	1.75
	

	201211-011
	God’s Gift
	106,500
	

	 
	$
	1.75
	

	201211-044
	Strader Family Trust
	31,950
	

	 
	$
	1.75
	

	201211-027
	Kentor Trust U/A dated 09/18/2002
	11,183
	

	 
	$
	1.75
	

	201211-034
	National Healthcare Services
	85,200
	

	 
	$
	1.75
	

	201211-035
	National Healthcare Services
	85,200
	

	 
	$
	1.75
	

	201211-036
	National Healthcare Services
	170,400
	

	 
	$
	1.75
	

	201211-046
	The Testman Trust
	11,250
	

	 
	$
	1.75
	

	201211-007
	Donald E Pogorzelski Trust
	75,000
	

	 
	$
	1.75
	

	201211-041
	Scott GRAT No. 5
	852,000
	

	 
	$
	1.75
	

	201211-037
	Piercey Trust
	106,500
	

	 
	$
	1.75
	

	201211-031
	Lilian R Kramer 2009 Trust
	112,500
	

	 
	$
	1.75
	

	201211-021
	I Melvin Kramer Special Revocable Trust
	112,500
	

	 
	$
	1.75
	

	201211-010
	Elisa Kenna Trust
	225,000
	

	 
	$
	1.75
	

	201211-029
	Kim Pegula and Terrence Pegula JT TEN
	180,000
	

	 
	$
	1.75
	

	201211-003
	Brian J Carruthers
	112,500
	

	 
	$
	1.75
	

	201211-019
	Holder Enterprises, LLC
	180,000
	

	 
	$
	1.75
	

	201211-042
	Sidney L McDonald
	180,000
	

	 
	$
	1.75
	

	201211-025
	Jeff Olson Consultant Retirement Trust
	112,500
	

	 
	$
	1.75
	

	201211-006
	David Savula and Beverly Savula JTWROS
	112,500
	

	 
	$
	1.75
	

	201211-043
	Stephen Lepley and Laura Jane Lepley TIC
	112,500
	

	 
	$
	1.75
	

	201211-022
	Ivie Family Limited Partnership
	112,500
	

	 
	$
	1.75
	

	201211-026
	John David Wine
	112,500
	

	 
	$
	1.75
	

	201211-033
	Mary Ann Evans
	112,500
	

	 
	$
	1.75
	

	201211-049
	Woodford Farm Trust
	112,500
	

	 
	$
	1.75
	

	201211-020
	Hubbard Properties, Inc.
	247,500
	

	 
	$
	1.75
	

	201211-005
	Carson Retained Annuity Trust
	112,500
	

	 
	$
	1.75
	

	201211-012
	Heiligbrodt Family Partnership
	213,000
	

	 
	$
	1.75
	

	201211-002
	Belmont Insurance Co, Inc.
	42,600
	

	 
	$
	1.75
	

	201211-001
	Argus Reinsurance, Ltd.
	106,500
	

	 
	$
	1.75
	

	201211-004
	Bubalo Family Trust
	42,600
	

	 
	$
	1.75
	

	201211-032
	Linda Formo Brandes Trust
	106,500
	

	 
	$
	1.75
	

	201211-018
	Helen Lovaas Trust FBO Theresa Bell
	21,300
	

	 
	$
	1.75
	

	201211-014
	Helen Lovaas Trust FBO Cindy Westwood
	21,300
	

	 
	$
	1.75
	

	201211-017
	Helen Lovaas Trust FBO Kathy Redenius
	21,300
	

	 
	$
	1.75
	

	201211-015
	Helen Lovaas Trust FBO Daniel Lovaas
	21,300
	

	 
	$
	1.75
	

	201211-016
	Helen Lovaas Trust FBO Frank Bartlett
	21,300
	

	 
	$
	1.75
	

	201211-013
	Helen Lovaas Trust FBO Christine Fennelly
	21,300
	

	 
	$
	1.75
	

	201211-047
	Ulrich Frindt Family Trust
	21,300
	

	 
	$
	1.75
	

	201211-024
	Jason & Paula Livingston
	42,600
	

	 
	$
	1.75
	

	201211-038
	Randall R Lunn
	21,300
	

	 
	$
	1.75
	

	201211-039
	Rue Family Trust
	106,500
	

	 
	$
	1.75
	

	201211-048
	Van Fleet Family Trust
	21,300
	

	 
	$
	1.75
	

	201211-023
	James Lauro
	45,000
	

	 
	$
	1.75
	

	201211-040
	Rukhsana N. Bukhari
	45,000
	

	 
	$
	1.75
	

	201211-045
	The Testman Trust
	45,000
	

	 
	$
	1.75
	

Page 7

	
								
	Number
	Holder
	Warrant
Shares
	 
	Exercise
Price

	201211-030
	Laurence M Demers
	37,500
	

	 
	$
	1.75
	

	201211-008
	Donald E Pogorzelski Trust
	225,000
	

	 
	$
	1.75
	

	201211-009
	Donald E Pogorzelski Trust
	180,000
	

	 
	$
	1.75
	

	201002-004
	J Piercey Trust
	28,400
	

	 
	$
	4.00
	

	201004-003
	Kentor Trust U/A dated 9/18/2002
	71,000
	

	 
	$
	5.00
	

	201004-011
	Laurence M Demers
	14,200
	

	 
	$
	5.00
	

	201004-012
	Zurlo Investment Trust
	14,200
	

	 
	$
	5.00
	

	201011-002
	National Healthcare Services
	142,000
	

	 
	$
	3.00
	

	201012-001
	Laurence M Demers
	30,000
	

	 
	$
	3.00
	

	201104-001
	Tregale Group Ltd
	31,863
	

	 
	$
	3.00
	

	201108-001
	Tregale Group Ltd
	1,300,000
	

	 
	$
	3.00
	

	201304-001
	Memorial Care Innovation Fund, LP
	90,273*
	

	 
	$ 5.25*
	

Page 8*Exhibit  10.18

Exhibit 10.18
THE SECURITIES REPRESENTED BY THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER ANY APPLICABLE STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A CURRENT AND EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS WITH RESPECT TO SUCH SECURITIES, OR AN OPINION SATISFACTORY TO THE ISSUER AND ITS COUNSEL TO THE EFFECT THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS.
AUTOGENOMICS, INC.
Promissory Note
 
	
			
	No. 201301-001
	  
	Vista, California

	$2,400,000.00
	  
	January 4, 2013

FOR VALUE RECEIVED, AutoGenomics, Inc., a Delaware corporation (“Maker” or the “Company”), hereby promises to pay to the order of A R Properties or registered assigns (“Holder”), the principal amount of Two Million Four Hundred Thousand Dollars ($2,400,000.00), together with interest thereon at the rate of eight and one half percent (8.5%) per annum (this “Note”), on or before March 31, 2013 (the “Maturity Date”), subject to the terms and conditions set forth hereinbelow.
1. Subordination.
(a) Subordination to Senior Indebtedness. The indebtedness evidenced by this Note, and the payment of the principal hereof and interest hereon, is wholly subordinated, junior and subject in right of payment, to the extent and in the manner hereinafter provided, to the prior payment of all Senior Indebtedness of the Company now outstanding or hereinafter incurred. “Senior Indebtedness” means the principal of, and premium, if any, and interest on (i) all indebtedness of the Company for monies borrowed from banks, trust companies, insurance companies and other financial institutions, including commercial paper and accounts receivable sold or assigned by the Company to such institutions, (ii) all indebtedness of the Company for monies borrowed by the Company from other persons or entities, (iii) obligations of the Company as lessee under leases of real or personal property, (iv) principal of, and premium, if any, and interest on any indebtedness or obligations of others of the kinds described above assumed or guaranteed in any manner by the Company, (v) deferrals, renewals, extensions and refundings of any such indebtedness or obligations described above, and (vi) any other indebtedness of the Company which the Company and the holders of more than 50% of the unpaid principal amount of the Company’s outstanding Subordinated Promissory Notes (the “Subordinated Notes”) may hereafter from time to time expressly and specifically agree in writing shall constitute Senior Indebtedness. Notwithstanding the foregoing, “Senior Indebtedness” shall not include indebtedness of the Company evidenced by the Subordinated Notes, which shall rank equally and ratably with this Note. 
(b) Rights of Holders Unimpaired. The provisions of this Section 1 are, and are intended solely, for the purposes of defining the relative rights of Holder and the holders of Senior Indebtedness and nothing in this Section 1 shall impair, as between the Company and Holder, the obligation of the Company, which is unconditional and absolute, to pay to Holder the principal thereof, in accordance with the terms of this Note, nor shall anything herein prevent Holder from exercising all remedies otherwise permitted by applicable law or hereunder upon default, subject to the rights set forth above of holders of Senior Indebtedness to receive cash, property or securities otherwise payable or deliverable to the holder of this Note.
2. Repayment.
(a) Repayment at the Maturity Date. The Company shall repay all, but not less than all, of the outstanding principal amount of this Note, and all accrued and unpaid interest thereon, effective as of the Maturity Date by mailing a corporate check in such amount payable to Holder at Holder’s address of record as contained herein or on file with the Company pursuant to notice given as provided herein, no later than ten (10) business days after the Maturity Date.
(b) Prepayment Prior to the Maturity Date. The Company may prepay all or any portion of the outstanding principal amount of this Note, together with all accrued and unpaid interest thereon, at any time or from time to time without premium or penalty.
(c) Cancellation of Subordinated Note. Immediately upon repayment in full of this Note, this Note shall no longer be deemed to be outstanding and all rights with respect to this Note shall immediately cease and terminate as of the date of such repayment.

Page 1

3. Requirements for Transfer. This Note shall not be sold or transferred unless either (i) this Note shall have been registered under the Securities Act of 1933, as amended (the “Act”), and all applicable state securities laws with respect thereto or (ii) the Company first shall have been furnished with an opinion of legal counsel, reasonably satisfactory to the Company, to the effect that such sale or transfer is exempt from the registration requirements of the Act and all applicable state securities laws with respect thereto.
4. Payment of Principal. All payments due and payable from Maker to Holder under this Note shall be made in lawful currency of the United States of America.
5. Default. Upon the occurrence of an Event of Default (as defined below), the entire unpaid portion of the principal amount of this Note, and all accrued and unpaid interest due Holder hereunder, shall automatically become due and payable. As used in this Note, “Event of Default” shall mean: (i) a receiver, trustee, custodian or similar officer is appointed for Maker, or for any substantial part of its property and such appointment or proceedings remain unstayed or undismissed for a period of 90 days, (ii) any bankruptcy, insolvency, reorganization, arrangement, readjustment of debt, dissolution, liquidation or similar proceedings under the laws of any jurisdiction is instituted (by petition, application or otherwise) against Maker and such appointment or proceedings remain unstayed or undismissed for a period of 90 days, (iii) Maker admits in writing its inability to pay its debts when due, (iv) Maker makes an assignment for the benefit of creditors, (v) Maker applies for or consents to the appointment of any receiver, trustee, custodian or similar officer for Maker or for any substantial part of its property, or (vi) Maker institutes (by petition, application or otherwise) or consents to any bankruptcy, insolvency, reorganization, arrangement, readjustment of debt, dissolution, liquidation or similar proceedings under the laws of any jurisdiction against Maker.
6. Replacement. Whenever this Note shall be surrendered at the principal executive office of the Company for transfer or exchange, accompanied by a written instrument of transfer in form reasonably satisfactory to the Company duly executed by Holder hereof or his, her or its attorney duly authorized in writing, the Company shall execute and deliver in exchange therefor a new Note or Notes, as may be requested by Holder, in the same aggregate unpaid principal amount and payable on the same date as the principal amount of the Note or Notes so surrendered; each such new Note shall be in such principal amount and registered in such name or names as Holder may designate in writing. Upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Note and of indemnity reasonably satisfactory to it, and upon reimbursement to the Company of all reasonable expenses incidental thereto, and upon surrender and cancellation of this Note (in case of mutilation) the Company will make and deliver in lieu of this Note a new Note of like tenor and unpaid principal amount.
7. General.
(a) Successors and Assigns. This Note, and the obligations and rights of the Company hereunder, shall be binding upon and inure to the benefit of the Company, Holder, and their respective heirs, successors and assigns.
(b) Notices. All notices, requests, consents and demands shall be made in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed telex or facsimile if sent during normal business hours of the recipient, if not, then on the next business day, (c) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the Company at 2980 Scott St, Vista, California, 92081, and to Holder at the applicable address on record with the Company or at such other address as the Company or Holder may designate by ten (10) days advance written notice to the other parties hereto.
(c) Governing Law. This Note shall be construed and enforced in accordance with, and the rights of the parties shall be governed by, the laws of the State of Delaware, without regard to its principles of choice of law.
(d) No Waiver. No delay or omission on the part of Holder in exercising any right under this Note shall operate as a waiver of such right or of any other right of Holder, nor shall any delay, omission or waiver on any one occasion be deemed a bar to or waiver of the same or any other right on any future occasion.
(e) Costs of Collection. The Company agrees to pay on demand all costs of collection, including reasonable attorney’s fees, incurred by Holder in enforcing the obligations of the Company under this Note.
 
(f) Confidentiality. By his, her or its acceptance hereof, Holder agrees that he, she or it will keep confidential and will not disclose, divulge or use for any unauthorized purpose any confidential, proprietary or secret information which Holder may obtain from the Company (i) pursuant to financial statements, reports and other materials submitted by the Company to 

Page 2

Holder or (ii) pursuant to visitation or inspection rights granted to Holder, unless such information is known, or until such information becomes known, to the public.
(g) Headings. The headings in this Note are for purposes of reference only and shall not limit or otherwise affect the meaning of any provision of this Note.

IN WITNESS WHEREOF, this Note has been executed and delivered on the date first above written by the undersigned authorized representative of the Company.
 
	
			
	AUTOGENOMICS, INC.

	a Delaware corporation

	 
	 

	By:  
	 
	/s/ Thomas V. Hennessey, Jr.

	 
	 
	Thomas V. Hennessey, Jr.

	 
	 
	Its CFO and COO

Page 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}]]